Study to show which is better for oxygen delivery & blood flow among levosimendan or milrinone in coronary artery surgeries
Phase 4
- Conditions
- Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
- Registration Number
- CTRI/2024/02/063388
- Lead Sponsor
- INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) TRIPLE VESSEL DISEASE
2) EJECTION FRACTION 35 - 55%
Exclusion Criteria
PATIENT REFUSAL
KNOWN ALLERGY TO STUDY DRUGS
COMBINED CARDIAC PROCEDURES
CONVERSION TO ON PUMP CABG
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method